IVDR: EU In Vitro Diagnostic Regulation Explained
The IVDR is the European regulation governing in vitro diagnostic medical devices, setting standards for safety, performance, and market approval across the EU.
Things worth knowing about "IVDR"
The IVDR is the European regulation governing in vitro diagnostic medical devices, setting standards for safety, performance, and market approval across the EU.
What is the IVDR?
The IVDR (In Vitro Diagnostic Medical Devices Regulation, EU Regulation 2017/746) is a European legal framework that governs all in vitro diagnostic (IVD) medical devices. These are products used to examine specimens derived from the human body – such as blood, urine, or tissue – outside of the body. Common examples include blood glucose monitors, pregnancy tests, COVID-19 rapid tests, and genetic diagnostic assays. The IVDR officially came into full effect on 26 May 2022, replacing the previous IVD Directive 98/79/EC.
Goals and Significance of the IVDR
The IVDR was introduced to establish higher safety and quality standards for diagnostic products across the European Union. The previous IVD Directive was considered insufficient to keep pace with rapid technological advances and growing patient safety demands. Key objectives of the IVDR include:
- Strengthening requirements for clinical performance evaluation and evidence generation
- Greater involvement of Notified Bodies in conformity assessment procedures
- Improved transparency through the EUDAMED European medical device database
- Enhanced post-market surveillance and vigilance obligations
- Clear risk-based classification of IVD devices into four classes (A, B, C, D)
Risk Classification Under the IVDR
The IVDR classifies in vitro diagnostic devices into four risk classes, each with corresponding regulatory requirements:
- Class A: Lowest risk (e.g., general laboratory instruments, specimen containers) – self-certification permitted
- Class B: Moderate risk (e.g., urine test strips, pregnancy tests) – Notified Body involvement required
- Class C: High risk (e.g., blood typing, hepatitis tests) – rigorous conformity assessment required
- Class D: Highest risk (e.g., HIV tests, blood donation screening) – strictest requirements, including EU reference laboratory involvement
Key Requirements for Manufacturers
Manufacturers of IVD products must meet a wide range of obligations under the IVDR in order to place their products on the European market:
- Clinical performance studies: Evidence of analytical and clinical performance must be provided
- Technical documentation: Comprehensive records covering design, manufacturing, and performance
- EUDAMED registration: Mandatory entry into the European medical device database
- UDI (Unique Device Identification): Unique product labelling for full traceability
- Post-Market Surveillance (PMS): Ongoing monitoring and reporting obligations after market placement
Difference Between IVDR and MDR
The IVDR is often mentioned alongside the MDR (Medical Device Regulation, EU 2017/745). While the MDR covers general medical devices such as pacemakers, implants, and wound dressings, the IVDR applies exclusively to diagnostic products used in vitro – that is, outside the human body. Together, both regulations form the modern European regulatory framework for medical devices.
Relevance for Patients and Healthcare
For patients, the IVDR means greater safety and reliability in diagnostic testing. By requiring robust clinical evidence and continuous post-market monitoring, the regulation ensures that only products with proven performance and safety remain on the market. This is particularly important for tests that directly influence treatment decisions – such as in cancer diagnostics, infectious disease testing, or genetic conditions.
References
- European Parliament and Council of the European Union: Regulation (EU) 2017/746 on in vitro diagnostic medical devices (IVDR), Official Journal of the EU, 2017.
- European Commission: IVDR – In Vitro Diagnostic Regulation. Official EU Commission information page on medical devices. https://health.ec.europa.eu/medical-devices-sector/in-vitro-diagnostic-medical-devices_en
- World Health Organization (WHO): Guidance on Regulation of Medical Devices. WHO Press, Geneva. https://www.who.int/medical_devices/en/
Verwandte Produkte
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, lactic acid bacteria, and Lactoferrin CLN®
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.